~ Buy the WYNZORA (betamethasone dipropionate; calcipotriene) Drug Profile, 2024 PDF Report in the Report Store ~

WYNZORA Drug Patent Profile

✉ Email this page to a colleague

When do Wynzora patents expire, and when can generic versions of Wynzora launch?

Wynzora is a drug marketed by MC2 and is included in one NDA. There are two patents protecting this drug.

This drug has forty-eight patent family members in twenty-eight countries.

The generic ingredient in WYNZORA is betamethasone dipropionate; calcipotriene. There are sixty-six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; calcipotriene profile page.

DrugPatentWatch^® Generic Entry Outlook for Wynzora

Indicators of Generic Entry

< Available with Subscription >

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for WYNZORA?
What are the global sales for WYNZORA?
What is Average Wholesale Price for WYNZORA?

Summary for WYNZORA

International Patents:	48
US Patents:	2
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Formulation / Manufacturing:	see details
What excipients (inactive ingredients) are in WYNZORA?	WYNZORA excipients list
DailyMed Link:	WYNZORA at DailyMed

Drug patent expirations by year for WYNZORA

Pharmacology for WYNZORA

Drug Class	Corticosteroid Vitamin D Analog
Mechanism of Action	Corticosteroid Hormone Receptor Agonists

US Patents and Regulatory Information for WYNZORA

WYNZORA is protected by two US patents.

Patents protecting WYNZORA

Topical composition
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mc2	WYNZORA	betamethasone dipropionate; calcipotriene	CREAM;TOPICAL	213422-001	Jul 20, 2020		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Mc2	WYNZORA	betamethasone dipropionate; calcipotriene	CREAM;TOPICAL	213422-001	Jul 20, 2020		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for WYNZORA

See the table below for patents covering WYNZORA around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Canada	2680405	COMPOSITION TOPIQUE DE POLYAPHRON AVEC VITAMINE D ET CORTICOSTEROIDE (POLYAPHRON TOPICAL COMPOSITION WITH VITAMIN D AND CORTICOSTEROID)	⤷ Sign Up
Brazil	112020019075	composição para aplicação tópica, método para fabricar uma composição para aplicação tópica, e, uso de uma combinação de alfa-tocoferol e hidroxianisol butilado	⤷ Sign Up
South Korea	20200135400	국소 조성물	⤷ Sign Up
European Patent Office	2139452	COMPOSITION TOPIQUE DE POLYAPHRON AVEC VITAMINE D ET CORTICOSTÉROÏDE (POLYAPHRON TOPICAL COMPOSITION WITH VITAMIN D AND CORTICOSTEROID)	⤷ Sign Up
China	104815329	Polyaphron topical composition with vitamin D and corticosteroid, application and manufacturing method thereof	⤷ Sign Up
European Patent Office	1970049	Composition topique du type polyaphron avec de la vitamine D et un corticosteroide (Polyaphron topical composition with vitamin D and corticosteroid)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration